Burden and risk factors for gastrointestinal symptom distress in HIV patients in the modern antiretroviral era

References

• Assefa, S., Erko, B., Medhin, G., Assefa, Z., & Shimelis, T. (2009). Intestinal parasitic infections in HIV/AIDS status, diarrhea and CD4 T-cell count. BMC Infectious Diseases, 9, 155–161. doi: 10.1186/1471-2334-9-155
   PubMed Web of Science ®Google Scholar
• Boulassel, M. R., Chomont, N., Pai, N. P., Gilmore, N., Sekaly, R. P., & Routy, J. P. (2012). CD4T cell nadir independently predicts the magnitude of the HIV reservoir after prolonged suppressive antiretroviral therapy. Journal of Clinical Virology, 53(1), 29–32. doi: 10.1016/j.jcv.2011.09.018
   PubMed Web of Science ®Google Scholar
• Bruce, R. D., Altice, F. L., & Friedland, G. H. (2008). Pharmacokinetic drug interactions between drugs of abuse and antiretroviral medications: Implications and management for clinical practice. Expert Revue of Clinical Pharmacology, 1(1), 115–127. doi: 10.1586/17512433.1.1.115
   PubMed Web of Science ®Google Scholar
• Cello, J. P., & Day, L. W. (2009). Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology, 136, 1952–1965. doi: 10.1053/j.gastro.2008.12.073
   PubMed Web of Science ®Google Scholar
• Chambers, L., Wilson, M. G., Rueda, S., Gogolishvili, D., Shi, Q., & Rourke, S. B. (2013). Evidence informing the intersection of HIV, aging, and health: A scoping review. Toronto: Ontario HIV Treatment Network. Retrieved July 14, 2015, from, http://www.ohtn.on.ca/Documents/Research/OHTN-Positive-Aging-Final-Report-2012-12.pdf
   Google Scholar
• Clay, P. G., & Crutchley, R. D. (2014). Noninfectious diarrhea in HIV seropositive individuals: A review of prevalence rates, etiology, and management in the era of combination antiretroviral therapy. Journal of Infectious Disease Therapy, 3, 103–122. doi: 10.1007/s40121-014-0047-5
   Google Scholar
• Dandekar, S. (2007). Pathogenesis of HIV in the gastrointestinal tract. HIV/AIDS Reports, 4, 10–15. doi: 10.1007/s11904-007-0002-0
   PubMedGoogle Scholar
• Dickinson, L., Khoo, S., & Back, D. (2010). Pharmacokinetics and drug-drug interactions of antiretrovirals: An update. Antiviral Research, 85(1), 176–189. doi: 10.1016/j.antiviral.2009.07.017
   PubMed Web of Science ®Google Scholar
• Dieleman, J. P., Jambroes, M., Gyssens, I. C., Sturkenboom, M. C., Stricker, B. H., Mulder, W. M., … Brinkman, K. (2002). Determinants of recurrent toxicity-driven switches of highly active antiretroviral therapy. The ATHENA cohort. AIDS, 16(5), 737–745. doi: 10.1097/00002030-200203290-00009
   Google Scholar
• Do, A. N., Rosenberg, E. S., Sullivan, P. S., Beer, L., Strine, T. W., Schulden, J. D., Fagan, J. L., … Skarbinski, J. (2014). Excess burden of depression among HIV infected persons receiving medical care in the United States: Data from the medical monitoring project and the behavioral risk factor surveillance system. PLoS One, 9(3). doi: 10.1371
   Web of Science ®Google Scholar
• Dodd, M., Janson, S., Facione, N., Faucett, J., Froelicher, E. S., Humphreys, J., … Taylor, D. (2001). Advancing the science of symptom management. Journal of Advanced Nursing, 33, 668–676. doi: 10.1046/j.1365-2648.2001.01697.x
   PubMed Web of Science ®Google Scholar
• Drossman, D. A. (2003). Cognitive-behavioural therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology, 125(1), 19–31. doi: 10.1016/S0016-5085(03)00669-3
   PubMed Web of Science ®Google Scholar
• Drossman, D. A., & Dumitrascu, D. L. (2006). Rome III: New standard for functional gastrointestinal disorders. Journal of Gastrointestinal and Liver Diseases, 15(3), 237–241.
   PubMedGoogle Scholar
• Engel, G. L. (1977). The need for a new medical model: A challenge for biomedicine. Science, 196(4286), 129–136. doi: 10.1126/science.847460
   PubMed Web of Science ®Google Scholar
• Foltin, R. W., Fischman, M. W., & Byrne, M. F. (1988). Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory. Appetite, 11, 1–14. doi: 10.1016/S0195-6663(88)80017-5
   PubMed Web of Science ®Google Scholar
• Gerich, M. E., Isfort, R. W., Brimhall, B., & Siegel, C. A. (2015). Medical marijuana for digestive disorders: High time to prescribe? American Journal of Gastroenterology, 110, 208–214. doi: 10.1038/ajg.2014.245
   PubMed Web of Science ®Google Scholar
• Grinzstein, B., Nguyen, B. Y., Katlama, C., Gatell, J. M., Lazzarin, A., Vittecoq, D., … Issacs, R. D. (2007). Safety and efficacy of the HIV-1 integrase inhibitor Raltegravir (MK-0518) in treatment experienced patients with multidrug resistant virus: A Phase II randomized controlled trial. Lancet, 369, 1261–1269. doi: 10.1016/S0140-6736(07)60597-2
   PubMed Web of Science ®Google Scholar
• Haney, M., Rabkin, J., Gunderson, E., & Foltin, R. W. (2005). Dronabinol and marijuana in HIV(+) marijuana smokers: Acute effects on caloric intake and mood. Psychopharmacology, 181, 170–178. doi: 10.1007/s00213-005-2242-2
   PubMed Web of Science ®Google Scholar
• Harding, R., Lampe, F. C., Norwood, S., Date, H. L., Clucas, C., Fisher, M., … Sherr, L. (2010). Symptoms are highly prevalent among HIV outpatients and associated with poor adherence and unprotected sexual intercourse. Sexual Transmitted Infections, 86(7), 520–524. doi: 10.1136/sti.2009.038505
   PubMed Web of Science ®Google Scholar
• Harding, R., Molloy, T., Easterbrook, P., Frame, K., & Higginson, I. J. (2006). Is antiretroviral therapy associated with symptom prevalence and burden? International Journal of STDs and AIDS, 17(6), 400–405. doi: 10.1258/095646206777323409
   PubMed Web of Science ®Google Scholar
• Hart, T. A., Moskowitz, D., Cox, C., Li, X., Ostrow, D. G., Stall, R. D., … Plankey, M. (2012). The cumulative effects of medication use, drug use, and smoking on erectile dysfunction among men who have sex with men. Journal of Sexual Medicine, 9(4), 1006–1113. doi: 10.1111/j.1743-6109.2011.02648.x
   Web of Science ®Google Scholar
• Heath, K. V., Montaner, J. S. G., Bondy, G., Singer, J., O’Shaughnessy, M. V., & Hogg, R. S. (2003). Emerging drug toxicities of highly active antiretroviral therapy for human immunodeficiency virus (HIV) infection. Current Drug Targets, 4(1), 13–22. doi: 10.2174/1389450033347109
   PubMed Web of Science ®Google Scholar
• Henningsen, P., Zimmerman, T., & Sattel, H. (2003). Medically unexplained physical symptoms, anxiety, and depression: A meta-analytic review. Psychosomatic Medicine, 65, 528–533. doi: 10.1097/01.PSY.0000075977.90337.E7
   PubMed Web of Science ®Google Scholar
• Hill, A., & Balkin, A. (2009). Risk factors for gastrointestinal adverse events in HIV treated and untreated patients. AIDS Revue, 11, 30–38.
   PubMed Web of Science ®Google Scholar
• HIV/AIDS Topics: Palliative Care 2006. World Health Organization, 2006. Retrieved from http://www.who.int/hiv/topics/palliative/PalliativeCare/en
   Google Scholar
• Hogg, R. S., Yip, B., Kully, C., Craib, K. J., O’Shaughnessy, M. V., Schechter, M. T., & Montaner, J. S. (1999). Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens. Canadian Medical Association Journal, 160(5), 659–665.
   PubMed Web of Science ®Google Scholar
• Hung, C. C., Chang, S. Y., & Ji, D. D. (2012). Entamoeba histolytica infection in men who have sex with men. Lancet Infectious Diseases, 12(9), 729–736. doi: 10.1016/S1473-3099(12)70147-0
   PubMed Web of Science ®Google Scholar
• Jones, M. P., Dilley, J. B., Drossman, D., & Cromwell, M. D. (2006). Brain-gut connections in function GI disorders: Anatomic and physiologic relationships. Neurogastroenterology Motility, 18, 91–103. doi: 10.1111/j.1365-2982.2005.00730.x
   PubMed Web of Science ®Google Scholar
• Justice, A. C., Holmes, W., Gifford, A. L., Rabeneck, L., Zackin, R., Sinclair, G., … Wu, A. W. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology, 54, S77–S90. doi: 10.1016/S0895-4356(01)00449-8
   PubMed Web of Science ®Google Scholar
• Karus, D., Raveis, V. H., Alexander, C., Hanna, B., Selwyn, P., Marconi, K., & Higginson, I. (2005). Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV/AIDS. Journal of Pain and Symptom Management, 30(5), 408–417. doi: 10.1016/j.jpainsymman.2005.04.011
   PubMed Web of Science ®Google Scholar
• Kisley, S., & Simon, G. (2006). An international study comparing the effect of medically explained and unexplained somatic symptoms on psychosocial outcome. Journal of Psychosomatic Research, 60, 125–130. doi: 10.1016/j.jpsychores.2005.06.064
   PubMed Web of Science ®Google Scholar
• Kotler, D. P. (2005). HIV infection and the gastrointestinal tract. AIDS, 19, 107–117. doi: 10.1097/00002030-200501280-00002
   PubMed Web of Science ®Google Scholar
• Kotler, D. P., Gaetz, H. P., Lange, M., Klein, E. B., & Holt, P. R. (1984). Enteropathy associated with the acquired immunodeficiency syndrome. Annals of Internal Medicine, 101, 421–428. doi: 10.7326/0003-4819-101-4-421
   PubMed Web of Science ®Google Scholar
• Kotler, D. P., Shimanda, T., Snow, G., Winson, G., Chen, W., Zhao, M., … Clayton, F. (1998). Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS, 12, 597–604. doi: 10.1097/00002030-199806000-00008
   PubMed Web of Science ®Google Scholar
• Lee, K. A., Gay, C., Portillo, C. J., Coggins, T., Davis, H., Pullinger, C. R., & Aouizerat, B. E. (2009). Symptom experience in HIV-infected adults: A function of demographic and clinical characteristics. Journal of Pain and Symptom Management, 38(6), 882–893. doi: 10.1016/j.jpainsymman.2009.05.013
   PubMed Web of Science ®Google Scholar
• Lerner, P., Guadalupe, M., Donovan, R., Hung, J., Flamm, J., Prindiville, T., … Dandekar, S. (2011). The gut mucosal viral reservoir in HIV infected patients is not a major source of rebound plasma viremia following interruption of highly active antiretroviral therapy. Journal of Virolology, 85(10), 4772–4782. doi: 10.1128/JVI.02409-10
   PubMed Web of Science ®Google Scholar
• Loew, B., Grafe, K., Kroenke, K., Zipfel, S., Quenter, A., Wild, B., … Herzog, W. (2003). Predictors of psychiatric comorbidity in medical outpatients. Psychosomatic Medicine, 65, 764–770. doi: 10.1097/01.PSY.0000079379.39918.17
   PubMed Web of Science ®Google Scholar
• Lorenz, K. A., Shapiro, M. F., Asch, S. M., Bozzette, S. A., & Hays, R. D. (2001). Associations of symptoms and health-related quality of life: Findings from a national study of persons with HIV infection. Annals of Internal Medicine, 134, 854–860. doi: 10.7326/0003-4819-134-9_Part_2-200105011-00009
   PubMed Web of Science ®Google Scholar
• Majowicz, S. E., Horrocks, J., & Bocking, K. (2007). Demographic determinants of acute gastrointestinal illness in Canada: A population study. BMC Public Health, 7, 162–169. doi: 10.1186/1471-2458-7-162
   PubMed Web of Science ®Google Scholar
• Majowicz, S. E., McNab, W. B., Sockett, P. N., Henson, T. S., Dore, K., Edge, V. L., … Wilson, J. B. (2006). Burden and cost of gastroenteritis in a Canadian community. Journal of Food Protection, 69(3), 651–659.
   PubMed Web of Science ®Google Scholar
• Malan, N., Su, J., Mancini, M., Yang, R., Wirtz, V., Absalon, J., & McGrath, D. (2010). Gastrointestinal tolerability and quality of life in antiretroviral-naïve HIV-1-infected patients: Data from the CASTLE study. AIDS Care, 22(6), 677–686. doi: 10.1080/09540120903334641
   PubMed Web of Science ®Google Scholar
• May, G. R., Gill, M. J., Church, D. L., & Sutherland, L. R. (1993). Gastrointestinal symptoms in ambulatory HIV infected patients. Digestive Diseases and Science, 38(8), 1388–1394. doi: 10.1007/BF01308593
   PubMed Web of Science ®Google Scholar
• Mocroft, A., Vella, S., Benfield, T. L., Chiesi, A., Miller, V., Gargalianos, P., … Lundgren, J. D. (1998). Changing patterns of mortality across Europe in patients affected with HIV-1: EuroSIDA Study Group. Lancet, 352(9142), 1725–1730. doi: 10.1016/S0140-6736(98)03201-2
   PubMed Web of Science ®Google Scholar
• Mussel, M., Kroenke, K., Spitzer, R. L., Williams, J. B., Herzog, W., & Lowe, B. (2008). Gastrointestinal symptoms in primary care: Prevalence and association with depression and anxiety. Journal of Psychosomatic Research, 64, 605–612. doi: 10.1016/j.jpsychores.2008.02.019
   PubMed Web of Science ®Google Scholar
• Naftali, T., Bar-Lev Schleider, L., Dotan, I., Lansky, E. P., Sklerovsky Bejaminov, F., & Konikoff, F. M. (2013). Cannabis induces a clinical response in patient’s with Crohn’s disease: A prospective placebo-controlled study. Clinical Gastroenterology and Hepatology, 11, 1276–1280. doi: 10.1016/j.cgh.2013.04.034
   PubMed Web of Science ®Google Scholar
• Palenicek, J., Nelson, K. E., Vlahov, D., Galai, N., Cohn, S., & Saah, A. J. (1993). Comparison of clinical symptoms of human immunodeficiency virus disease between intravenous drug users and homosexual men. Archives of Internal Medicine, 153, 1806–1812. doi: 10.1001/archinte.1993.00410150094009
   PubMed Web of Science ®Google Scholar
• Panel on Antiretroviral Guidelines. (2015). Guidelines for the use of antiretroviral agents in HIV 1 infected adults and adolescents. Department of Health and Human Services. Retrieved from https://aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf
   Google Scholar
• Penzak, S. R., Rreddy, Y. S., & Grimsley, S. R. (2000). Depression in patients with HIV infection. American Journal of Health Systems Pharmacy, 57, 376–386.
   PubMed Web of Science ®Google Scholar
• Raboud, J., Lesosky, M., Sterling, S., Phillips, E., Walmsley, S., & Bayoumi, A. (2007). An estimate of the proportion of symptoms reported in self-administered questionnaires that are captured as adverse drug events in an observational database. HIV Clinical Trials, 8(5), 311–319. doi: 10.1310/hct0805-311
   PubMed Web of Science ®Google Scholar
• Raboud, J., Su, D., Burchell, A. N., Gardner, S., Walmsley, S., Bayoumi, A. M., … Loutfy, M. R. (2013). Representativeness of an HIV cohort of the sites from which it is recruiting: Results from the Ontario HIV Treatment Network (OHTN) cohort study. BMC Medical Research Methodology, 13, 31–39. doi: 10.1186/1471-2288-13-31
   PubMed Web of Science ®Google Scholar
• Radloff, L. S. (1977). The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401. doi: 10.1177/014662167700100306
   Web of Science ®Google Scholar
• Regnault, A., Marfatia, S., Louie, M., Mear, I., Meunier, J., & Viala-Danten, M. (2009). Satisfactory cross-cultural validity of the ACTG symptom distress module in HIV-1 infected antiretroviral-naïve patients. Clinical Trials, 6(6), 574–584. doi: 10.1177/1740774509352515
   PubMed Web of Science ®Google Scholar
• Rourke, S. B., Gardner, S., Burchell, A. N., Raboud, J., Rueda, S., Bayoumi, A. M., … Rachlis, A. (2013). Cohort profile: The Ontario HIV Treatment Network Cohort Study (OCS). International Journal of Epidemiology, 42, 402–411. doi: 10.1093/ije/dyr230
   PubMed Web of Science ®Google Scholar
• Sargeant, J. M., Majowicz, S. E., & Snelgrove, J. (2008). The burden of acute gastrointestinal illness in Ontario, Canada, 2005–2006. Epidemiology and Infection, 136(4), 451–460. doi: 10.1017/S0950268807008837
   PubMed Web of Science ®Google Scholar
• Scallan, E., Majowicz, S. E., Hall, G., Banerjee, A., Bowman, C. L., Daly, L., … Angulo, F. J. (2005). Prevalence of diarrhoea in the community in Australia, Canada, Ireland, and the United States. International Journal of Epidemiology, 34, 454–460. doi: 10.1093/ije/dyh413
   PubMed Web of Science ®Google Scholar
• Selwyn, P. A., Alcabes, P., Hartel, D., Buono, D., Schoenbaum, E. E., Klein, R. S., … Friedland, G. H. (1992). Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection. New England Journal of Medicine, 327, 1697–1703. doi: 10.1056/NEJM199212103272401
   PubMed Web of Science ®Google Scholar
• Sharpstone, D., Neild, P., Crane, R., Taylor, C., Hodgson, C., Sherwood, R., … Bjarnason, I. (1999). Small intestinal transit, absorption, and permeability in patients with AIDS with and without diarrhea. Gut, 45, 70–76. doi: 10.1136/gut.45.1.70
   PubMed Web of Science ®Google Scholar
• Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science Medicine, 32(6), 705–714. doi: 10.1016/0277-9536(91)90150-B
   PubMed Web of Science ®Google Scholar
• Sherr, L., Lampe, F., Norwood, S., Leake-Date, H., Fisher, M., Edwards, S., … Harding, R. (2007). Successive switching of antiretroviral therapy is associated with high psychological and physical burden. International Journal of STD & AIDS, 18(10), 700–704. doi: 10.1258/095646207782193821
   PubMed Web of Science ®Google Scholar
• Sherr, L., Lampe, F., Norwood, S., Leake-Date, H., Harding, R., Johnson, M., … Anderson, J. (2008). Adherence to antiretroviral treatments in patients with HIV in the UK: A study of complexity. AIDS Care, 20(4), 442–448. doi: 10.1080/09540120701867032
   PubMed Web of Science ®Google Scholar
• Siddiqui, U., Vini, E. J., Chandarana, K., Leong, J., Ramsetty, S., Schiliro, D., & Poles, M. (2007). Prevalence and impact of diarrhea on health related quality of life in HIV-infected patients in the era of highly active antiretroviral therapy. Journal of Clinical Gastroenterology, 41(5), 484–490. doi: 10.1097/01.mcg.0000225694.46874.fc
   PubMed Web of Science ®Google Scholar
• Silverberg, M. J., Jacobson, L. P., French, A. L., Witt, M. D., & Gange, S. J. (2009). Age and racial/ethnic differences in the prevalence of reported symptoms in human immunodeficiency virus-infected persons on antiretroviral therapy. Journal of Pain and Symptom Management, 38(2), 197–207. doi: 10.1016/j.jpainsymman.2008.08.007
   PubMed Web of Science ®Google Scholar
• Solano, J. P., Gomes, B., & Higginson, I. J. (2006). A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. Journal of Pain and Symptom Management, 31(1), 58–69. doi: 10.1016/j.jpainsymman.2005.06.007
   PubMed Web of Science ®Google Scholar
• Thompson, T., Lee, M. G., Clarke, T., Mills, M., Wharfe, G., & Walters, C. (2012). Prevalence of gastrointestinal symptoms among ambulatory HIV patients and a control population. Annals of Gastroenterology, 25(3), 243–248.
   Google Scholar
• Thompson, W. G., Heaton, K. W., Smyth, G. T., & Smyth, C. (2000). Irritable bowel syndrome in general practice: Prevalence, characteristics, and referral. Gut, 46, 78–82. doi: 10.1136/gut.46.1.78
   PubMed Web of Science ®Google Scholar
• Tinmouth, J., Kandel, G., Tomlinson, G., Walmsley, S., Steinhart, H. A., & Glazier, R. (2007). Systematic review of strategies to measure HIV-related diarrhea. HIV Clinical Trials, 8(3), 155–163. doi: 10.1310/hct0803-155
   PubMed Web of Science ®Google Scholar
• Tseng, A., Szadkowski, L., Walmsley, S., Salit, I., & Raboud, J. (2013). Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients. Annals Pharmacotherapy, 47(11), 1429–1439. doi: 10.1177/1060028013504075
   PubMed Web of Science ®Google Scholar
• Turner, R. J., Wheater, B., & Lloyd, D. A. (1995). The epidemiology of social stress. American Sociological Revue, 60(1), 104–125. doi: 10.2307/2096348
   Web of Science ®Google Scholar
• Vogl, D., Rosenfeld, B., Breitbard, W., Thaler, H., Passik, S., McDonald, M., & Portenoy, R. K. (1999). Symptom prevalence, characteristics, and distress in AIDS outpatients. Journal of Pain and Symptom Management, 18(4), 253–262. doi: 10.1016/S0885-3924(99)00066-4
   PubMed Web of Science ®Google Scholar
• Wheeler, J. G., Sethi, D., Cowden, J. M., Wall, P. G., Rodrigues, L. C., Tompkins, D. S., … Roderick, P. J. (1999). Study of infectious intestinal diseases in England: Rates in the community, presentation in general practice, and reported to national surveillance. British Medical Journal, 318(7190), 1046–1050. doi: 10.1136/bmj.318.7190.1046
   PubMed Web of Science ®Google Scholar
• Wilcox, C. M., & Saag, M. S. (2008). Gastrointestinal complications of HIV infection: Changing priorities in the HAART era. Gut, 57, 861–870. doi: 10.1136/gut.2006.103432
   PubMed Web of Science ®Google Scholar
• de Wit, M. A., Koopmans, M. P., Kortbeek, L. M., Wannet, W. J., Vinje, J., van Leusden, F., … van Duynhoven, Y. T. (2001). Sensor, a population-based cohort of gastroenteritis in the Netherlands, incidence and etiology. American Journal of Epidemiology, 154(7), 666–674. doi: 10.1093/aje/154.7.666
   PubMed Web of Science ®Google Scholar
• Woolridge, E., Barton, S., Samuel, J., Osorio, J., Dougherty, A., & Holdcroft, A. (2005). Cannabis use in HIV for pain and other medical symptoms. Journal of Pain and Symptom Management, 29(4), 358–367. doi: 10.1016/j.jpainsymman.2004.07.011
   PubMed Web of Science ®Google Scholar